Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Capstone Investment Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Capstone Investment Advisors
from 13F filings
Historical chart of Capstone Investment Advisors investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Capstone Investment Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Capstone Investment Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-09-30 | $8.8M | 7.5M | 1.17 |
| 2024-06-30 | $8.1M | 7.5M | 1.08 |
| 2024-03-31 | $12M | 13M | 0.94 |
| 2023-12-31 | $17M | 18M | 0.99 |
| 2023-09-30 | $9.3M | 10M | 0.93 |
More positions owned by Capstone Investment Advisors
View all positions for Capstone Investment Advisors
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1